白歌 Baig, Mirza Muhammad Faran Ashraf Ph.D.

 

Name Card
rp02755 picture

Dr 白歌 Baig, Mirza Muhammad Faran Ashraf Ph.D.

Title:
Post-doctoral Fellow

Contact Information
rp02755 picture
Office:

Dr 白歌 Baig, Mirza Muhammad Faran Ashraf Ph.D.

Title:
Post-doctoral Fellow

Short Biography:

Dr. MMFAB received his Doctor of Pharmacy & MPhil (Drug Delivery, MechanoPharmacology, Biophysics) from BZU, Pakistan and Ph.D degree from Nanjing University (NJU), China (Chemistry, Bio-sensing, & Bio-imaging). Recently, he designs DNA-based novel functional & bio-active nanomaterials at HKU to apply in Restorative Dentistry, Oral Microbiology & Oncology, Regenerative Therapeutics, and Stem Cells Research. He published in the top journals e.g., Nano Letters, indexed in Harvard University Press.

Professional Qualifications
YearAwarding InstitutionQualification
2012Bahauddin Zakariya UniversityDoctor of Pharmacy
2014Bahauddin Zakariya UniversityMPhil in Pharmaceutical Chemistry
2020Nanjing UniversityPhD in Chemistry
2012Pakistan Pharmacy CouncilRegistered Pharmacist
Biography

Membership:

  1. Chinese Chemical Society (Membership # 180410758) from April 22, 2018 to April 22, 2022.
  2. Registered Pharmacist (R.Ph.), Pakistan Pharmacy Council, Punjab, Pakistan from August 2012 to date.

Previous:

(i) Ph.D. scholar at Nanjing University, Nanjing, China. (2016 - 2020) (Top 124th University, Top 60th Chemistry and Pharmacy majors, QS University ranking 2021).

(ii) Medical Information Officer (M.I.O) at Novartis Pharmaceuticals (2012 - 2015), (Top 5th Pharmaceutical Company). 

(iii) Lecturer at Multan Medical and Dental College Pakistan to teach Pharmacology, Physiology and Biochemistry to MBBS and BDS students.

Present Address: Faculty of Dentistry, Prince Philip Dental Hospital, The University of Hong Kong, Hong Kong.  

Phone: +85261592470 E-mail: mirzafaran-ashraf@hotmail.com; faran@hku.hk; faran@smail.nju.edu.cn

URLs: http://www.facdent.hku.hk/about/our-staff.php,

http://www.facdent.hku.hk/about/staff-profile.php?shortname=faran,

https://scholar.google.com/citations?user=A3s4iwMAAAAJ&hl=en

https://www.researchgate.net/profile/Mirza_Muhammad_Faran_Ashraf_Baig

https://xxh.nju.edu.cn/Members/GraduateStudents/20200120/i69360.html.

Research Productivity: 

Publications: 48 (17+31), Citations: 300, H-index: 10, Total impact factor: 162 (55.5+106.5)

Peer review activity as a reviewer 

Participated in a peer review process of the following journals as a reviewer 

1. Journal of the American Chemical Society (IF: 15.4)

2. Analytical Chemistry (IF: 6.9)

3. Biosensors and Bioelectronics (IF: 10.6)         

4. Environmental Chemistry Letters (IF: 9.0)

5. Journal of Biomaterials Applications (IF: 2.2)  

6. J. of Drug Del. Sci. & Technology (IF: 3.9)

7. Applied Nanoscience (IF: 3.6)  

8. J. of Pharmaceutical & Biomedical Analysis (IF: 3.9)

9. BMC Oral Health (IF: 2.7)

10. International Journal of Nanomedicine (IF: 6.4)     

11. Journal of Molecular Liquids (IF: 6.1)

12. Asian J. of Pharmaceutical Sci. (IF: 6.5)    

13. Artificial Cells, Nanomed. & Biotech. (IF: 5.6)

14. Scientific Reports (IF: 4.3) 

15. Biocell (IF: 1.2)

16. Nanomedicine (IF: 6.4)

17. Value in Health (IF: 5.7).

18. Journal of Pharmacy and Pharmacology (IF: 3.7)

19. Journal of Biomechanics (IF: 2.7).

Technical skills, Expertise, and Research area

  1. Mechano-Pharmacology & Biomedical-Imaging:Designing DNA based imaging probes for cellular targeting to track mechanical cellular processes.
  2. Biophysical-Chemistry & Cellular-Mechanotransduction: Determining signal transduction pathways, necessary for the mechanical and biophysical cellular signaling for the proper growth, development and maturation of organs.
  3. DNA Nanobiotechnology & Drug Delivery: Synthesis of nanostructures from DNA, polymers, and peptides for designing drug nanocarriers and nanodevices. Circularization of single-stranded DNA strands to synthesize scaffold for programmed self-assembly to construct rigid and stiff DNA nano-lattices to study mechano-biology and estimating pico-newton forces.

Conferences, Trainings, Achievements, and Awards

  1. An invited speaker at the 4th Int'l Conference on Nanochemistry (ICN 2022) going to be held on April 22-24, 2022 in Youngor Central Hotel, Suzhou, Jiangsu, China. https://www.scet-meeting.org/conference/ICN2022/.
  2. A keynote speaker at the “Int'l Conference on Information Technology and Biomedical Engineering” (ICITBE 2021) going to be held on December 24-26, 2021 in Trilec International Hotel, Nanchang, Jiangxi, China. http://www.icitbe.org/keynote.asp.
  3. An invited speaker in the “International Conference on Medicine Science and Engineering” (ICMSE 2021) held in Wuhan, China on November 26, 2021. http://icmse2021.com/index.php/keynote-speakers/.
  4. A key speaker in the “Biomedical Engineering and Health Science” (BEHS 2021) held on November 27, 2021. http://behs2021.com/index.php/keynote-speakers/.   
  5. A key speaker in “The 2nd International Conference on Biotechnology & Clinical Pharmacology and Toxicology” (BCPT 2021) held on November 28, 2021. http://bcpt2021.org/index.php/keynote-speakers/.    
  6. An invited keynote speaker in the “International Conference on Nanotechnology and Material Science” held in New York, USA on November 10-11, 2021, and in Madrid, Spain on November 19-20, 2021. https://www.longdom.com/nanomaterials.
  7. An invited keynote speaker in the “International Meet on Public Health and Healthcare Management” (PUBLICHEALTHMEET 2021) held online Chaired by Prof. Dr. Steven J. Soldin of National Institute of Health (NIH), USA on November 04-05, 2021.

https://www.albedomeetings.com/cms/pdfs/publichealthmeet2021-tentative-program.pdf.

  1. A speaker in the “Virtual Conference on Nanomedicine and Drug Delivery” (VCNMDD 2021) held on October 25-26, 2021. https://conferentousglobal.com/conferences/nanodelivery/speakers.  
  2. A featured speaker at the “BIT’s 13th world congress on Cancer” with the theme of “New Mechanisms to Best Cures” held on September 25-27, 2021 in Dalian International Conference Center, Dalian, China.
  3. .
  4. A keynote speaker at a conference on “Bioinformatics and Health Science” (BHS2021) held online on September 24-26, 2021. http://bhs2021.com/index.php/keynote-speakers/.  
  5. Featured speaker at “The 4th World Congress on Pharmacology and Drug Discovery” (Pharmacology Congress 2021) going to be held on September 22-23 in Barcelona, Spain. https://pharmacologycongress.org/speakers.  
  6. A Keynote speaker at “The 3rd Int'l Conference on Graphene and Nanomaterials” (GNN 2021) and “The 8th Global Conference on Polymer and Composite Materials” (PCM 2021) held on August 16-19, 2021. http://www.academicconf.com/video?confname=gnn2021.
  7. Featured speaker at the “Int'l symposium on Biomedical Engineering and Computational Biology” (BECB 2021) held on August 13-15, at Nanchang Hangkong University, Nanchang, Jiangxi, China.
  8. .
  9. A keynote speaker at the Webinar on “Biosensor and Bioelectronics 2021” (Biosensor 2021), held on June 21, 2021 in Brussels, Belgium. https://www.longdom.com/webinars/biosensor/scientific-program.
  10. A keynote speaker at the 3rd Int'l Conference on Nanomedicine (NanoMed 2021) held on July 16-18, 2021 in JinJiang Hotel, Kunming, Yunnan, China. https://www.confjuly.org/conference/NanoMed/1363s8517.html.
  11. A keynote speaker at the virtual event of “World Congress on Neurology” (Neurology 2021) held online on June 17-18, 2021. https://crgconferences.com/neurologycongress/performers.  
  12. A keynote speaker at a conference of “Polymeric, Metallic, and Composite Materials 2021” (PMCM 2021) held on May 29-30 in Wuhan, Hubei, China. http://www.pmcm.org.cn/pmpcorg/bk_23990520.html.
  13. A speaker in a seminar at the Faculty of Dentistry, The University of Hong Kong held on May 20th, 2021 in HKU, Hong Kong. https://facdent.hku.hk/docs/events/20210520_Seminar_Dr_Baig.pdf.  
  14. A keynote speaker at the Int'l Conference on Nanochemistry (ICN 2021) held during April 23-25, 2021 in Xi’an Grand Dynasty Culture Hotel, Xi'an, China. https://www.scet-meeting.org/conference/ICN2021/.
  15. A speaker on the “Annual Scientific Meeting 2020” at the Faculty of Dentistry, The University of Hong Kong held on December 10th, 2020. https://asm.facdent.hku.hk/2020/oral.php.
  16. A Speaker in the 1st Tianyuan International Workshop on Pharmacy held on June 19th, 2020 in Department of Pharmacy, Nanjing Medical University, China. http://yjsy.njmu.edu.cn/2020/0616/c10422a172478/page.htm.
  17. Keynote speaker at World Congress on Cardiology and Heart Diseases (World Cardiology, 2020), held on March 30-31, 2020, at Osaka, Japan.
  18. ,   https://coalesceresearchgroup.com/uploads/confirences/pdfs/12-03-2019_1042am_88986.pdf.
  19. Keynote speaker at the 2nd Edition of World Nanotechnology Conference (World Nano 2020), going to be held on 27-29 April 2020, in Crowne Plaza Hotel, Baltimore Downtown (Inner Harbor), 105W Fayette Street, Baltimore, MD 21201 USA.
    • .
  20. A moderator of a scientific session and an invited keynote speaker on The International Conference on Heart & Clinical Cardiology Research (Heart Congress 2019) held on 14-15 November 2019 in IP city Hotel, Osaka, Japan. https://crgconferences.com/past-conference-report/heart-congress-2019.

https://crgconferences.com/heartcongress/2019/performers.

  1. Speaker and poster presentation in the 6th International Pharmacy Academic Forum held at China Pharmaceutical University, Nanjing, China on May 18, 2019.
  2. An invited speaker at “The 17th Sino-Foreign Exchange Week at “China Pharmaceutical University”, held on April 15-19th 2019.
  3. . http://wywy.cpu.edu.cn/c4/34/c9508a115764/page.htm.
  4. Interviewed by a Chinese “ZijinShan News” for a “Media Talk” about the experience of living and research in China. http://m.zijinshan.org/news/218594903162803015?from=singlemessage
  5. Participant in “The 13th International Conference on Bio-analytical Chemistry” by China Chemical Society held in July 2018 in International Conference Center, Xi’an, China. 
  6. A guest of honor at “The 16th Sino-Foreign Cultural Exchange Week of China Pharmaceutical University” held on May 7-11, 2018.
  7. Invitation as a keynote speaker in various, Pharmacy, Chemistry, Medical, Material and polymer science conferences held in the USA, UK, Canada, China, Australia, Germany, Italy, Spain, Sweden, Switzerland, Singapore, Dubai, Taiwan and, Thailand.
  8. An article about media talk regarding my life/research in China was published by Jiangsu Government on 23 May, 2016.
  9. .
  10. Participant in the 5th International Conference on DNA Nanotechnology held on July, 2016 at Xianlin Hotel of Nanjing Normal University, Nanjing, China.

SCHOLARSHIPS, ACHIEVEMENTS, TRAININGS, AND AWARDS                                                                 

  1. A training seminar on “Responsible Conduct of Research” (RCR) held on May 5, 2021 organized by the Research Integrity Core of the University of Hong Kong, Hong Kong SAR.
  2. A training about the “Protection from Discrimination and Harassments” held on Oct 8, 2021 organized by the Equal Opportunity Unit of the University of Hong Kong, Hong Kong SAR.
  3. The “Outstanding PhD Student Award” of China Scholarship Council (CSC) in an award ceremony hosted by the “Chinese Ministry of Education” held in 2019 at Peking University, Beijing, China.
  4. “Outstanding International Ph.D. graduate award” by Jiangsu government in 2019 at Nanjing University, Nanjing, China.
  5. China Government Scholarship to study Ph.D. at Nanjing University, China; (September 2016 to August 2020).

https://hwxy.nju.edu.cn/_t485/4d/e1/c6018a151009/page.htm.

  1. China Government Scholarship to study the Chinese language at Nanjing University, China; from September 2015 to June 2016.
  2. The “National Master Award” for the Cardiovascular-Metabolic (CVM) group of Novartis Pharma in 2015 at Pearl Continental Hotel, Lahore, Pakistan.
  3. Novartis Selling Excellence (NSE) Training in January 2015 at Ramada Hotel, Multan, Pakistan.
  4. “Detailing Champion” in “Customer Solution Model Training” (NCSM) held by Novartis Academy of Excellence, in 2014 at Pearl Continental Hotel, Rawalpindi, Islamabad, Pakistan.
  5. Novartis Code of Conduct and Anti-Bribery Training at Hotel One, Lahore, Pakistan.
  6. National Quiz Champion during the 3rd Quarter 2014 Cycle Meeting held at Pearl Continental Hotel, Lahore, Pakistan.
  7. “National Top Achievement Award” of Novartis Pharma, Galvus/GalvusMet brand with the YTD achievement of 120 % in 2013.
  8. Excellent Performance Award during “Basic Training Course” (BTC) held by the Novartis Academy of Excellence in 2012, at Marriot Hotel, Karachi Pakistan.
  9. Three consecutive times, qualified the PPSC (Punjab Public Service Commission) written exams for the post of BPS-17 (Pharmacist) during 2013-2015.

https://www.ppsc.gop.pk/WrittenResults/press%20note%20PHARMACIST%2017F2015.pdf. https://www.ppsc.gop.pk/WrittenResults/press%20note%20PHARMACIST%20208C2013.pdf.

 

PUBLICATIONS                                                               

Publication: 57 (1st author 20 + 37), Citations: 570, H-index: 15, Impact factor: 247 (1st author 86 + 161), i10-index: 22

As a first author/ Corresponding author*

  1. Baig, M.M.F.A., ... Xia, Xing-Hua*. A DNA nano-device simultaneously activating the EGFR and integrin for enhancing cytoskeletal activity and cancer cell treatment. Nano Letters, 2019. 19 (10): p. 7503-7513. I.F. = 11.1.
  2. Zhang, Q-W1., Baig, M.M.F.A1…. Xia, Xing-Hua*. Liposomal valinomycin mediated cellular K+ leak promotes apoptosis of cancer cells. Journal of Controlled Release, 2021. 337: p. 317-328. (Equal contribution). I.F. = 9.7.
  3. Baig, M.M.F.A., Dissanayaka, W.L., Zhang, Chengfei*, … 2D DNA nanoporous scaffold promotes osteogenic differentiation of pre-osteoblasts. International J. of Biological Macromolecules, 2021. 188: p. 657-669. I.F. = 6.9.
  4. Baig, M.M.F.A*., Zhang, Chengfei …, Nisar, N. Treatment of Wilms’ nephroblastoma cancer cells via EGFR targeting of dactinomycin loaded DNA-nanowires. Journal of Pharmaceutical Investigation, 2021. 51: p. 233-242. C.S. = 10.3 (scopus).
  5. Baig, M.M.F.A., ... Xia, Xing-Hua*. DNA nanotechnology for modulating the growth and development of neurons. CCS Chemistry, 2021. 3 (9): p. 2381–2393. C.S. = 22.5.
  6. Baig, M.M.F.A., . Xia, Xing-Hua*. DNA nanotechnology as a tool to develop molecular tension probes for bio-sensing and bio-imaging applications: An up-to-date review. Nano-structures & Nano-objects, 2020. 23: p. 100523. C.S. = 9.1.
  7. Baig, M.M.F.A., Zhang, Chengfei*, … Digging nanochannels through the infectious biofilm to target the resistant bacteria, 2021. (Under preparation).
  8. Baig, M.M.F.A., Ting, Z., Neelakantan, P., Zhang, Chengfei*, … Development and functionalization of DNA-nanostructures for biomedical applications. Journal of the Chinese Chemical Society, 2021. 68 (2): p. 228-238. I.F. = 1.9.
  9. Baig, M.M.F.A*., Zhang, Chengfei …, Mudassir, J. The effective transfection of a low dose of negatively charged drug loaded DNA-nanocarriers into cancer cells via scavenger receptors. Journal of Pharmaceutical Analysis, 2021. 11 (2): p. 174-182. I.F. = 4.7.
  10. Baig, M.M.F.A*., …, Ansari, M.T. Targeting folate receptors to internalize the bleomycin loaded DNA-nanotubes into prostate cancer xenograft CWR22R cells. Journal of Molecular Liquids, 2020. p. 113785. I.F. = 6.1.
  11. Baig, M.M.F.A*.,…, Ansari, M.T. Design, synthesis and evaluation of DNA nano-cubes as a core material protected by the alginate coating for oral administration of anti-diabetic drug. Journal of Food and Drug Analysis, 2019. 27(3): p. 805-814. I.F. = 6.0.
  12. Baig, M.M.F.A., …, Ansari, M.T. Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus. Biomedicine & Pharmacotherapy, 2018. 97: p. 1250-1258. I.F. = 6.5.
  13. Baig, M.M.F.A*.,…, Ansari, M.T. DNA scaffold nanoparticles coated with HPMC/EC for oral delivery. International Journal of Pharmaceutics, 2019. 562: p. 321-332. I.F. = 5.8.
  14. Baig, M.M.F.A*.,…, Ansari, M.T. Synthesis of ligand functionalized ErbB-3 targeted novel DNA nano-threads loaded with the low dose of doxorubicin for efficient in vitro evaluation of the resistant anti-cancer activity. Pharmaceutical Research, 2020. 37: p. 75. I.F. = 4.2.
  15. Baig, M.M.F.A*.,…, Ansari, M.T. The Integrin facilitated internalization of camptothecin loaded DNA nano-fibers for high efficiency anticancer effects. Drug Delivery and Translational Research, 2020. 10: p. 1381–1392. I.F. = 4.6.  
  16. Baig, M.M.F.A., and Xia, Xing-Hua*. The PA-receptor mediated internalization of carboplatin loaded poly-anionic DNA nanowires for effective treatment of resistant hepatic-cancer HepG-2 cells. Applied Nanoscience, 2020. 10: p. 1915–1926. I.F. = 3.6.
  17. Xin, G#., Baig, M.M.F.A#.,. Xia, Xing-Hua, Xiao, Shou-Jun*. 2D DNA arrays assembled from DX-coupling tiles based on a circular scaffold of 10 full-turns perimeter. Organic & Biomolecular Chemistry, 2021. I.F. = 3.8. (Equal contribution), (Revision Requested).
  18. Baig, M.M.F.A*.,…, Ansari, M.T. Synthetic NRG-1 functionalized DNA nanospindles towards HER2/neu targets for in vitro anti-cancer activity assessment against breast cancer MCF-7 cells. Journal of Pharmaceutical and Biomedical Analysis, 2020. 182: p. 113133. I.F. = 3.9.
  19. Baig, M.M.F.A*.,…, Ansari, M.T. PLL‑alginate and the HPMC‑EC hybrid coating over the 3D DNA nanocubes as compact nanoparticles for oral administration. Applied Nanoscience, 2019. 9 (8): p. 2105-2115. I.F.= 3.6.
  20. Baig, M.M.F.A*.,…, Ansari, M.T. Evaluation of chitosan/eudragit hybrid coating over cubic DNA nanospheres with superior stability and therapeutic outcomes. Journal of Drug Delivery Science and Technology, 2019. 52: p. 577-585. I.F. = 3.9.
  21. Baig, M.M.F.A*.,…, Ansari, M.T. Chitosan-coated rectangular DNA nanospheres for better outcomes of anti-diabetic drug. Journal of Nanoparticle Research, 2019. 21 (5): p. 98. I.F. = 2.2.
  22. Baig, M.M.F.A*., et al., Assessment of compliance in cardiovascular patients in Nishter Hospital, Multan, Pakistan. Asian Journal of Pharmaceutics, 2015. 9: p. 56-59. I.F. = 0.4.

As a co-author

  1. Lai, W-F*., Baig, M.M.F.A2, Wong, W-T., Zhu, Baoting*. Epigallocatechin-3-gallate in functional food development: From concept to reality. Trends in Food Science & Technology, 2020. 102: p. 271-279. I.F. = 12.5.
  2. Afshan, N., .. Baig, M.M.F.A4., Xiao, Shou-Jun*. DNA nanotubes assembled from tensegrity triangle tiles with circular DNA scaffolds. Nanoscale, 2017. 9 (44): p. 17181-17185. 102: p. 271-279. I.F. = 7.7.
  3. Ullah, S., Li, Z*., … Baig, M.M.F.A5. Biomarkers of pyrethroid toxicity in fish. Environmental Chemistry Letters, 2019. 17(2): p. 945-973. I.F. = 9.0.
  4. Naveed, M., … Baig, M.M.F.A5.,…Zhou, Q-G*. Chitosan oligosaccharide (COS): An overview. International Journal of Biological Macromolecules, 2019. 129C: p. 827-843. I.F. = 6.9.
  5. Li Y-P*,... Baig, M.M.F.A4.,…., Xu, M*. Research progress of phosphatidylinositol 4-kinase and its inhibitors in inflammatory diseases. European Journal of Pharmacology, 2021. 907: p. 174300. I.F. = 4.4. 
  6. Saleem A*,... Baig, M.M.F.A5 …., Chemical characterisation and appraisal of antidiabetic potential of Terminalia citrina extract in streptozotocin induced hyperglycaemia in Wistar rats. Archives of Physiology and Biochemistry, 2021. I.F. = 4.0
  7. Akhtar MF*,... Baig, M.M.F.A5. Appraisal of anti-arthritic and anti-inflammatory potential of folkloric medicinal plant peganum harmala. Endocrine, Metabolic & Immune Disorders - Drug Targets, 2021. I.F. = 2.8
  8. Akhtar MF*,... Baig, M.M.F.A4. Maternotoxicity and fetotoxicity in Rattus norvegicus albinus exposed to tramadol during the late phase of pregnancy. Birth Defects Research, 2021. I.F. = 2.3
  9. Abbas, M., Baig, M.M.F.A2., Hu, yiqiao*, Zhu, Hai-Liang*. A novel DNA nanocarrier for high efficiency anticancer therapy. Journal of Pharmaceutical Analysis, 2020. 11 (3): p. 330-339. I.F. = 4.7.
  10. Liu Z., Baig, M.M.F.A3.,…., Zhou, X*. Therapeutic approach for global myocardial injury using bone marrow-derived mesenchymal stem cells by cardiac support device in rats. Biomedical Microdevices, 2021. 23 (5): p. 1-10 I.F. = 2.8.
  11. Mohamed. K. S., … Baig, M.M.F.A5.,. An overview of healthcare systems in Comoros: The effects of two decades of political instability. Annals of Global Health, 2021. 87 (1): p. 84-99. I.F. = 2.4.
  12. Kassim, S. A., … Baig, M.M.F.A4.,. Comparative study of the health care delivery systems in the Indian ocean: What can Comoros islands learn from Mauritius and Seychelles? Journal of Healthcare for Poor and Underserved, 2021. 32 (3): p. 1236-1264. I.F. = 1.4.
  13. Cuican L., Baig, M.M.F.A5.,…., Zhou, X*. Therapeutic advances in cardiac targeted drug delivery: from theory to practice, Journal of Drug Targeting, 2020. 29 (3): p. 235-248. I.F. = 3.4.
  14. Akhtar MF*,... Baig, M.M.F.A4. Tylophora hirsuta L. leaf extract attenuates alloxan-induced diabetes in mice by suppressing oxidative stress and α-amylase. Asian Pacific Journal of Tropical Biomedicine, 2021. 11(9): p. 394-404. I.F. = 1.5.
  15. Cui, X#., Naveed, M#., Baig, M.M.F.A3.,… Han, L*. Therapeutic effects of traditional Chinese medicine formula Qianlie Tongli decoction on chronic prostatitis/chronic pelvic pain syndrome induced by peptide T2 in mice. Journal of Pharmacy and Pharmacology, 2020. 72 (10): p. 1436-1444. I.F. = 3.7.
  16. Ahmed, S.A., … Baig, M.M.F.A7., …. Xia, Xing-Hua, Kang, Wang*. Mass transfer modulation and gas mapping based on covalent organic frameworks-covered theta micropipette. Analytical Chemistry, 2020. 92(10); p. 7343–7348. I.F. = 6.9. 
  17. Ahmed, S.A., … Baig, M.M.F.A5.,…., Xia, Xing-Hua., Kang, Wang*. pH-dependent slipping and exfoliation of layered covalent organic framework. Chemistry - A European Journal, 2020. 26 (57): p. 12996-13001. I.F. = 5.2.
  18. Mikrani, R., … Baig, M.M.F.A5.,…., Zhou, X*. Pharmacokinetic advantage of ASD device promotes drug absorption through the epicardium. Pharmaceutical Research, 2020. 37: p. 173. I.F. = 4.2.
  19. Wang, W., . Baig, M.M.F.A3., Zhou, X*. Experimental rodent models of chronic prostatitis and evaluation criteria. Biomedicine & Pharmacotherapy, 2018. 108: p. 1-7. I.F.= 6.5.
  20. Liu, Y., . Baig, M.M.F.A4., Zhou, X*. TRPM8 channels: A review of distribution and clinical role. European Journal of Pharmacology, 2020. p. 173312. I.F.= 4.4.    
  21. Liu, Z., . Baig, M.M.F.A6., Zhou, X*. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations. European Journal of Pharmacology, 2020. p. 173049. I.F.= 4.4.
  22. Naveed, M., .. Baig, M.M.F.A4.,…., Zhou, X.* Suppression of TGP on myocardial remodeling by regulating the NF-κB pathway. Biomedicine & Pharmacotherapy, 2018. 108: p. 1460-1468. I.F. = 6.5.
  23. Abbas, M., .. Baig, M.M.F.A4., Dingding C*. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Current Problems in Cancer, 2018. 43(1): p. 5-17. I.F. = 3.1.
  24. Farooq, M.A., … Baig, M.M.F.A5., Wang, Bo*. Denatured food protein-coated nanosuspension: A promising approach for anticancer delivery of hydrophobic drug. Journal of Molecular Liquids, 2020. 303: p. 112690. I.F. = 6.1.
  25. Kassim, S. A., … Baig, M.M.F.A5., Chen, R*. Polymorphism is associated with decreased risk and better prognosis for colorectal cancer patients. Archives of Medical Research, 2019. 50 (2): p. 55-62. I.F. = 2.2.
  26. Naveed, M., Baig, M.M.F.A7., Li, Changxing*. A Review of medicinal plants in cardiovascular disorders: benefits and risks. The American Journal of Chinese Medicine, 2020. 48 (2): p. 259-286. I.F. = 4.6.
  27. Essien, E.E., …. Baig, M.M.F.A5 ……. Drinking water nitrate and cancer risk: A systematic review and meta-analysis. Archives of Environmental and Occupational Health, 2020. p. 1-9. I.F. = 1.6.
  28. Hasnat, M., … Baig, M.M.F.A6.,… Zhang, L.*, Zhenzhou, J.* Mitochondria-dependent apoptosis in triptolide-induced hepatotoxicity is associated with the Drp1 activation. Toxicology Mechanisms and Methods, 2019. p. 124-133. I.F. = 2.9.
  29. Saleem A.*, ... Baig, M.M.F.A5. HPLC analysis, cytotoxicity and safety study of Moringa oleifera Lam. (wild type) leaf extract. Journal of Food Biochemistry, 2020. 44 (10): p. e13400. I.F. = 2.7.
  30. Kassim, S. A., Cote A.*,… Baig, M.M.F.A5., Chen, R.* Factors influencing treatment outcomes of tuberculosis patients attending health facilities in Galkayo Puntland, Somalia. Journal of Public Health, 2020. p. 1-9. I.F. = 2.3.
  31. Saleem A.*, ... Baig, M.M.F.A5. Chemical characterization, in vitro antioxidant, cytotoxicity, and safety evaluation of Polystichum brauni (spenn.) Fee roots. Natural Product Research, 2020. p. 1-6. I.F. = 2.8.
  32. Akhtar MF*,... Baig, M.M.F.A4. Anticancer natural medicines: An overview of cell signaling and other targets of anticancer phytochemicals. European Journal of Pharmacology, 2020. 888: p. 173488. I.F. = 4.4. 
  33. Akhtar MF*,... Baig, M.M.F.A4. Chemical characterization and anti-arthritic appraisal of Monotheca buxifolia  methanolic extract in Complete Freund's Adjuvant-induced arthritis in Wistar rats. Inflammopharmacology, 2021. 29 (2): p. 393-408. I.F. = 4.4.
  34. Farooq, M.A., …. Baig, M.M.F.A6…. Wang, Bo*. Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy. Daru Journal of Pharmaceutical Sciences, 2019. 27: p. 853-862. I.F. = 3.1.
  35. Liu, Y., .. Baig, M.M.F.A7., Zhou, X-H*. Chronic prostatitis/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines. Fundamental & Clinical Pharmacology, 2020. 34 (2): p. 160-172. I.F. = 2.7.  
  36. Khan, G.J., …. Baig, M.M.F.A6., Sun, L*. In vitro pre-treatment of cancer cells with TGF-B1: A novel approach of Tail vein lung cancer metastasis mouse model for anti-metastatic studies. Current molecular pharmacology, 2019. 12(4): p. 249-260. I.F. = 3.3.
  37. Khan, G.J., ….. Baig, M.M.F.A7., Sun, L*. Pharmacological effects and potential therapeutic targets of DT-13. Biomedicine & Pharmacotherapy, 2018. 97: p. 255-263. I.F. = 6.5.

 

BOOK CHAPTERS                                                               

  1. Ahsan, A…. Baig, M.M.F.A4. Chapter 1: Physiology of Endocrine System and Related Metabolic Disorders. In: M. Akash, edited, Physiology of Endocrine System and Related Metabolic Disorders, 1st edition: Springer Nature International Publishing, Switzerland AG @ 2021, pp. 3-41. DOI: 10.1007/978-3-030-45923-9_1.
  2. Ahsan, A…. Baig, M.M.F.A4… Tian, W-X*.  Chapter 9: Analytical Techniques for the Assessment of Drug Stability. In: M. Akash, edited, Drug Stability and Chemical Kinetics, 1st edition: Springer Nature International Publishing, Singapore @ 2020, pp. 121-145. DOI: 10.1007/978-981-15-6426-0_9.
  3. Khan, A…. Baig, M.M.F.A4… Chapter 12: Stability Studies of Vaccines. In: M. Akash, edited, Drug Stability and Chemical Kinetics, 1st edition: Springer Nature International Publishing, Singapore @ 2020, pp. 167-185. DOI: 10.1007/978-981-15-6426-0_12.
 
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!